Arcturus Therapeutics Holdings (ARCT) Net Cash Flow (QoQ) (2018 - 2026)
Arcturus Therapeutics Holdings (ARCT) Net Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcturus Therapeutics Holdings | 164.57 Mn | -46.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -335.65% |
| Dec 31, 2025 | 72.37% |
| Sep 30, 2025 | 21.36% |
| Jun 30, 2025 | -2.00% |
| Mar 31, 2025 | -13,286.67% |
| Dec 31, 2024 | 99.35% |
| Sep 30, 2024 | 17.52% |
| Jun 30, 2024 | -677.69% |
| Mar 31, 2024 | 82.10% |
| Dec 31, 2023 | -74.60% |
| Sep 30, 2023 | -122.84% |
| Jun 30, 2023 | 179.07% |
| Mar 31, 2023 | -141.45% |
| Dec 31, 2022 | 436.64% |
| Sep 30, 2022 | -26.60% |
| Jun 30, 2022 | 28.79% |
| Mar 31, 2022 | -17.12% |
| Dec 31, 2021 | -144.74% |
| Sep 30, 2021 | 46.71% |
| Jun 30, 2021 | -943.43% |